Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report
作者
Xiuning Le,Christina S. Baik,Byoung Chul Cho,Jonathan W. Riess,Zofia Piotrowska,Adrianus J. de Langen,Sarah B. Goldberg,Jonathan W. Goldman,Noemı́ Reguart,Yoshimasa Shiraishi,Helen Ambrose,Paula G. Fraenkel,Brayan Merchan Ruiz,Paul E. Smith,Kwan Ho Tang,Helena A. Yu